Current Trends in Forensic Toxicology Symposium
Overview
Join François Espourteille for our workshop "Rapid DART-MS Screen for Benzodiazepines in Urine Enabled by DART (Direct Analysis in Real Time) Technology" and discover the power of DART-MS in providing selective results, reducing false positives and negatives, and enabling rapid addition of new target analytes.
Learn about our chromatography-free screening approach for benzodiazepines and their metabolites in urine, including alprazolam, clonazepam, diazepam, and more. This method measures 14 analytes in 96 samples with a throughput of 23 seconds per sample.
Learning Objectives:
- Understand the principles of DART-MS and its advantages over IA-based screening.
- Learn the rapid, chromatography-free screening method for benzodiazepines.
- Gain insights into sample preparation and analysis using EVOQ DART-TQ+ mass spectrometer.
The workshop was part of the 2025 Online Symposium on Current Trends in Forensic Toxicology by the CFSRE. The symposium, themed “Innovating for a Smarter, Sustainable, and Efficient Future in Forensic Toxicology,” took place from May 12 - 16, 2025.
Enhance your knowledge of advanced screening techniques and improve accuracy and efficiency in measuring benzodiazepines. Elevate your skills and stay ahead in the field of analytical chemistry!
Speaker
François Espourteille
Application Development Manager, Bruker Applied Mass Spectrometry
François Espourteille brings over 25 years of expertise in LC-MSMS applications. He earned a BS and MS from The College of William and Mary in Virginia and received a PhD from Rutgers University, followed by a post-doctoral position at Rensselaer Polytechnic Institute. He joined Cohesive Technologies of Franklin, MA in the application group and subsequently managed the application group for Aria and Transcend platforms within Thermo Fisher Scientific until 2014.
For the following decade, François has focused on clinical/toxicological LC-MSMS assays, high-throughput workflows, and 2D LCMS platforms as a consultant. He joined Bruker Applied Mass Spectrometry (BAMS) in 2021 as the DART-MS and Triple Quadrupole Application Manager.
For Research Use Only. Not for use in clinical diagnostic procedures.